Hyperbaric oxygen

Show results for

Unknown (509)
Genomics (24)
Transcriptomics (18)
Proteomics (4)
Clinical (1)
Metabolomics (1)

Organisms

Mus musculus (9)
Homo sapiens (6)
Alphavirus (4)
Anemia (4)
Archaea (4)
Bacteria (4)
Betaherpesvirinae (4)
Borrelia (4)
Clostridium perfringens (4)
Cowpox virus (4)
Cytomegalovirus (4)
Dengue virus (4)
EFO:0001352 (4)
Hepatitis B virus (4)
Human alphaherpesvirus 1 (4)
Human betaherpesvirus 5 (4)
Human immunodeficiency virus (4)
Influenza A virus (4)
Influenza C virus (4)
Japanese encephalitis virus group (4)
Listeria monocytogenes (4)
Mammarenavirus (4)
Miscanthus x giganteus (4)
Mus musculus (4)
Mycobacterium tuberculosis (4)
Rattus (4)
Sarbecovirus (4)
Rattus norvegicus (3)
Anguilla anguilla (1)
Drosophila melanogaster (1)

Organisms

Homo sapiens (7)
Mus musculus (7)
Anguilla anguilla (1)
Drosophila melanogaster (1)
Rattus norvegicus (1)

Repository

ENA (23)
geo (14)
biostudies-arrayexpress (5)
pride (4)
MetaboLights (1)

Tissue

Heart (2)
Brain (1)
Organic molecular entity (1)
Rete mirabile (1)

Disease

Prostatic Neoplasms (1)

Technology Type

Mass Spectrometry (4)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Gel-based experiment (1)
Shotgun proteomics (1)
Top-down proteomics (1)

Instrument Platform

BGISEQ-500 (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2022 (4)
2021 (3)
2026 (3)
2025 (3)
2017 (2)
2024 (2)
2012 (1)
2011 (1)
2010 (1)
2009 (1)
2023 (1)
2020 (1)
2004 (1)

Metabolite Name

[(Z)-[3-[(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpent-4-enylidene]amino] sulfate (1)
2-Naphthalenecarboxamide, 1-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]- (1)
(11R)-16-methoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene-11,17-diol (1)
(2S)-1-[(2E)-2-[(2S)-6-carboxy-2-carboxylato-2,3-dihydro-1H-pyridin-1-ium-4-ylidene]ethylidene]-5-[(3R,4S,5S,6R)-3-[(3R,4S,5S,6S)-6-carboxylato-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-oxido-2,3-dihydroindol-1-ium-2-carboxylate (1)
5-(3-((1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl)-1H-indol-1-yl)pentanoicacid (1)
Val-Asn-Val-Asp-Glu (1)
[(2R,3S,4R,5S)-5-[4-[[(1R)-1-[(7S)-2-amino-7-methyl-4-oxo-7,8-dihydro-1H-pteridin-6-yl]ethyl]amino]phenyl]-3,4-dihydroxyoxolan-2-yl]methyl phosphate (1)
Thr-Phe-Glu-Glu-Asp (1)
Ala-Arg-Asp-Glu-Thr (1)
Phe-Ala-Gly-Lys-Gln (1)
8-oxido-4-oxo-1H-quinoline-2-carboxylate (1)
(1R,4S,5R,7S,11S)-5-chloro-2,10-dioxatricyclo[5.3.1.04,11]undecan-4-ol (1)
(1R,3R,8R,12S,13R,17R,18Z,20Z,24R,25S,26S)-12-hydroxy-17-[(1R)-1-hydroxyethyl]-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2'-oxirane]-11,22-dione (1)
Regorafenib monohydrate (1)
(1R,4aR)-8,8-dimethyl-2-oxospiro[4a,6a,7,9-tetrahydro-4H-pentaleno[1,6a-c]pyran-1,2'-oxirane]-5-carboxylate (1)
(1S,5S,6S)-5-(Hydroxymethyl)-6-(3,5-dimethoxy-4-hydroxyphenyl)-8-oxabicyclo[3.2.1]octa-3-ene-2-one (1)
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylate (1)
DTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose (1)
DTDP-4-oxo-2-deoxy-alpha-D-pentos-2-ene (1)
(3R,4S,9R,11R)-29-(4-hydroxyphenyl)-3-methoxy-4-methylnonacosane-9,11-diol (1)
{3-[6,9,17,19,21-pentahydroxy-5-(3-hydroxyphenyl)-18-[3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-4,12,14-trioxapentacyclo[11.7.1.0(2),(1)(1).0(3),.0(1),(2)]henicosa-2(11),3(8),9,15(20),16,18-hexaen-13-yl]phenyl}oxidanesulfonic acid (1)
[(2S,3R,4R,5R,6S)-4,5-dihydroxy-2-[[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl]oxy]-6-methyloxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate (1)
[3-[ethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate (1)
Ser-Asp-His-Arg (1)
(20Z)-4,6,12,23-tetrachloropentacyclo[20.2.2.110,14.115,19.02,7]octacosa-1(24),2,4,6,10(28),11,13,15,17,19(27),20,22,25-tridecaene-5,13,16,24-tetrol (1)
6-({17,19-dioxo-5,7,9,20-tetraoxahexacyclo[11.7.0.0(2),(1).0(3),.0,.0(1),(1)]icosa-1(13),2(10),11,14(18)-tetraen-12-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
Val-TyrMe-OH (1)
Pro-Phe-Ala-Thr-Glu (1)
1-Arachidonoyl-3-docosahexaenoyl-sn-glycerol (1)
2,3,4,7,8,9,15,21,22,23,28-undecahydroxy-14-(hydroxymethyl)-12,27,31,34-tetraoxo-13,25,32,35-tetraoxaoctacyclo[14.13.3.3(1),(2).0,(3).0,(1)(1).0(1),(2).0(1),(2).0(2),(3)(3)]pentatriaconta-1,3,5(30),6,8,10,19,21,23-nonaene-20-carboxylic acid (1)

First Public Date

2026 (6)
2025 (4)
2022 (4)
2024 (2)
2023 (2)
2021 (2)
2020 (1)
2017 (1)
2014 (1)

Study status

Not provided (1)

Study type

Transcription profiling by array (3)
Unknown experiment type (1)
RNA-seq of coding RNA (1)
Interventional (1)

Release Date

2023 (71)
2021 (70)
2025 (70)
2024 (60)
2022 (60)
2020 (38)
2018 (27)
2019 (23)
2017 (19)
2016 (16)
2015 (14)
2014 (9)
2026 (8)
2012 (7)
2013 (7)
2010 (5)
2011 (4)
2009 (4)
2007 (1)
2006 (1)

Lab affiliation

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland, and Department of Cardiothoracic Surgery, Jena University Hospital, Jena, Germany (2)
Associate professor, Department of Biomedical laboratory sciences and chemical engineering, Bergen University College, Bergen, Norway. (1)
Institute of Zoology, University of Innsbruck, Innsbruck, Austria (1)

Location

United Kingdom (1)

Keyword

Medical Oxygen (1)
Stage IA ovarian epithelial cancer (1)
Stage IB ovarian epithelial cancer (1)
Stage IC ovarian epithelial cancer (1)
Stage IIA ovarian epithelial cancer (1)
Stage IIB ovarian epithelial cancer (1)
Stage IIC ovarian epithelial cancer (1)
Stage IIIA ovarian epithelial cancer (1)
Stage IIIB ovarian epithelial cancer (1)
Stage IIIC ovarian epithelial cancer (1)
Stage IA ovarian germ cell tumor (1)
Stage IB ovarian germ cell tumor (1)
Stage IC ovarian germ cell tumor (1)
Stage IIA ovarian germ cell tumor (1)
Stage IIB ovarian germ cell tumor (1)
Stage IIC ovarian germ cell tumor (1)
Stage IIIA ovarian germ cell tumor (1)
Stage IIIB ovarian germ cell tumor (1)
Stage IIIC ovarian germ cell tumor (1)
Stage IA cervical cancer (1)
Stage IB cervical cancer (1)
Stage IIA cervical cancer (1)
Stage IIB cervical cancer (1)
Stage III cervical cancer (1)
Stage I endometrial carcinoma (1)
Stage II endometrial carcinoma (1)
Stage III endometrial carcinoma (1)
Stage I uterine sarcoma (1)
Stage II uterine sarcoma (1)
Stage I bladder cancer (1)

Previous page
1 / 56
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 56
Next page

Sort by:

Relevance

Page size

Proteome analysis of pig heart tissue to study the molecular consequences of hyperbaric oxygen treatment

The overall goal of the project was to confirm the presence of different energetic states of mitochondrial subpopulations depending on their subcellular localization within cardiomyocytes, i.e., subsarcolemmal (SSM) and interfibrillar mitochondria (IFM). Here we analysed proteomic changes upon treat...

ORGANISM(S): Sus scrofa domesticus (domestic pig)

2024-06-22 | PXD047678 | Pride